The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox-Reference-Cited by-同舟云学术

The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox

Author:

Bloch Evan M.¹^ORCID,Sullivan David J.²³,Shoham Shmuel⁴,Tobian Aaron A. R.¹,Casadevall Arturo²³^ORCID,Gebo Kelly A.⁴

Affiliation:

1. Department of Pathology Johns Hopkins University School of Medicine

2. Department of Molecular Microbiology, Johns Hopkins Bloomberg School of Public Health

3. Department of Immunology, Johns Hopkins Bloomberg School of Public Health

4. Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine

Abstract

Monkeypox is an infection caused by the monkeypox virus (MPXV). The clinical findings in monkeypox include fever and rash.

Funder

HHS | NIH | NHLBI | NHLBI Division of Intramural Research

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

Reference109 articles.

1. WHO. 2022. WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. Accessed August 16.

2. CDC. 2022. 2022 monkeypox outbreak global map. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html. Accessed October 11 2022.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献